Author name: Emily Crane

Emily Crane is a writer, producer, and editor who has covered politics, health, business, and finance for publications like The Atlantic. She's also the host of the All Work All Play Podcast. She graduated from Northwestern University's Medill School of Journalism with a focus on investigative reporting and data visualization.

Avatar of Emily Crane
2THQIOTS3JDITMZFW3PACXJQXM

Study links infant lotion use to paraben exposure

A recent biomonitoring study published in the Journal of Exposure Science and Environmental Epidemiology has found that lotion use is a strong predictor of paraben exposure in young infants, raising new concerns about personal care product safety for this vulnerable population. The study, characterized by its authors as the “first paper to report paraben levels […]

Study links infant lotion use to paraben exposure Read More »

107386526 17102774692023 03 01t183627z 95571214 rc24lz9u1qcj rtrmadp 0 lilly insulin

Pharmaceutical stocks rise as Trump pauses tariffs but not for China

Shares of some drugmakers rose on Wednesday after President Donald Trump said he would pause steep tariff rates on dozens of countries, temporarily easing fears about the impact of potential tariffs on pharmaceuticals imported into the U.S.  Trump on Wednedsay announced he would reduce tariffs on most countries to 10% for 90 days, but would

Pharmaceutical stocks rise as Trump pauses tariffs but not for China Read More »

108128285 1744118642800 108128285 1744118584405 gettyimages 477336658 BLOOMBERG TECH

Digital health startup Transcarent takes Accolade private in $621 million deal

Digital health startup Transcarent on Tuesday announced it completed its acquisition of Accolade in a deal valued at roughly $621 million.  Transcarent first announced the acquisition in January, and the company said it has received all necessary shareholder and regulatory approvals to carry out the transaction. Accolade shareholders received $7.03 per share in cash, and its common stock will

Digital health startup Transcarent takes Accolade private in $621 million deal Read More »

YJ37ZOZSFZFW7K4MEVOROVJVWE

Inside the supply chain playbook for cosmetics manufacturers

Global supply chain instability continues to impact the cosmetics and personal care industry. According to a 2023 McKinsey & Company report, over 70% of consumer goods companies experienced supply chain disruptions in the past year, with the beauty sector particularly vulnerable due to complex ingredient sourcing, regulatory demands, and shifting consumer preferences. In response, cosmetics

Inside the supply chain playbook for cosmetics manufacturers Read More »

gerard t hooft portrait special breakthrough prize winning physicist

Breakthrough Prize Winner Gerard ’t Hooft Says Quantum Mechanics Is ‘Nonsense’

In the pantheon of modern physics, few figures can match the quiet authority of Gerard ’t Hooft. The Dutch theoretical physicist, now a professor emeritus at Utrecht University in the Netherlands, has spent much of the past half-century reshaping our understanding of the fundamental forces that knit together reality. But ’t Hooft’s unassuming, soft-spoken manner

Breakthrough Prize Winner Gerard ’t Hooft Says Quantum Mechanics Is ‘Nonsense’ Read More »

Dennis Gaitsgory

Dennis Gaitsgory Wins Breakthrough Prize for Solving Part of Math’s Grand Unified Theory

The Langlands program has been described by mathematician Edward Frankel as the “grand unified theory of mathematics.” Conceived by Robert Langlands in 1967, the program includes numerous conjectures that were intended to connect disparate mathematical realms: number theory and harmonic analysis. In the 1990s, a similar connection between geometry and harmonic analysis was noticed, and

Dennis Gaitsgory Wins Breakthrough Prize for Solving Part of Math’s Grand Unified Theory Read More »

107433690 17194212132024 05 28t062413z 640806831 rc26x7av36ac rtrmadp 0 health obesity forecast

Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound

President Donald Trump on Friday dropped a Biden administration proposal to have Medicare cover obesity drugs, including popular but costly GLP-1 treatments such as Novo Nordisk‘s Wegovy and Eli Lilly‘s Zepbound. But the Centers for Medicare and Medicaid Services said it may reconsider coverage of those drugs in the future, according to a fact sheet on the rule. The

Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound Read More »

108118628 1742416271662 gettyimages 2205908176 dji 20250319115928 0058 d s4oqhdxu

Medicare, Medicaid agency cuts jobs from minority health office, other divisions, as RFK Jr. guts U.S. health department

The Centers for Medicare & Medicaid Services has slashed jobs from its minority health office and other divisions, CNBC has learned, as Robert F. Kennedy Jr. upends the U.S. health department.  During a virtual all-hands meeting with employees on Friday, CMS acting Administrator Stephanie Carlton detailed some of the specific offices at the agency impacted

Medicare, Medicaid agency cuts jobs from minority health office, other divisions, as RFK Jr. guts U.S. health department Read More »

Scroll to Top